Translational Drug Development
18
1
4
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
11.1%
2 terminated/withdrawn out of 18 trials
83.3%
-3.2% vs industry average
0%
0 trials in Phase 3/4
30%
3 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (18)
Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors
Role: collaborator
Trial to Evaluate Safety and Tolerability of GP-2250 in Combination With Gemcitabine
Role: collaborator
Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies
Role: collaborator
NAP in Combination With Docetaxel Following Obinutuzumab Pretreatment in Subjects With Checkpoint Inhibitor Pretreated Advanced or Metastatic NSCLC
Role: collaborator
Study Evaluating the Ketogenic Diet in Patients With Metastatic Pancreatic Cancer
Role: lead
PK and Dose Escalation and Expansion Study of DST-2970
Role: collaborator
Trial to Evaluate Safety, PD & PK of IV Study Drug, QN-302, in Pts w/ Advanced or Metastatic Solid Tumors
Role: collaborator
Safety, Tolerability, PK, Anti-Tumor Activity of STP705 in Subjects With Advanced/Metastatic or Surgically Unresectable Solid Tumors Who Are Refractory to Standard Therapy
Role: collaborator
SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma (SURVIVE)
Role: collaborator
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors
Role: collaborator
Pilot Study Using Molecular Profiling to Find Potential Targets & Select Treatments for Pts With Met br ca
Role: lead
A Pilot Study Utilizing Proteomic and Genomic Profiling for Patients With Metastatic Breast Cancer
Role: lead
A Pilot Study of Dociparstat Sodium (ODSH) in Acute Myeloid Leukemia
Role: collaborator
Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer
Role: collaborator
Phase 2 Study to Assess the Efficacy & Safety of Gemcitabine + Nab Paclitaxel With or Without Dociparstat in Metastatic Pancreatic Cancer Patients
Role: collaborator
Utilizing Multiomic Advanced Diagnostics to Identify CDK 4/6 Inhibitor Response Predictors and a Post-treatment Multiomic Signature for Patients With ER+/HER2- Metastatic Breast Cancer
Role: collaborator
Triple Negative Breast Cancer Biomarker Study
Role: collaborator
A Study of Therapy Selected by Molecular/Metabolic Profiling in Patients With Previously Treated Metastatic Pancreatic Cancer
Role: lead
All 18 trials loaded